Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 15857541)

1.

Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.

Bell MJ, Stockwell DC, Luban NL, Shirey RS, Shaak L, Ness PM, Wong EC.

Pediatr Crit Care Med. 2005 May;6(3):363-6.

PMID:
15857541
2.

Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.

Schuettpelz LG, Behrens D, Goldsmith MI, Druley TE.

J Pediatr Hematol Oncol. 2009 Nov;31(11):870-2. doi: 10.1097/MPH.0b013e3181b7eda2.

PMID:
19829151
3.

Ceftriaxone-induced hemolytic anemia: case report and review of literature.

Northrop MS, Agarwal HS.

J Pediatr Hematol Oncol. 2015 Jan;37(1):e63-6. doi: 10.1097/MPH.0000000000000181. Review.

PMID:
24878619
4.

Ceftriaxone-induced immune hemolytic anemia.

Neuman G, Boodhan S, Wurman I, Koren G, Bitnun A, Kirby-Allen M, Ito S.

Ann Pharmacother. 2014 Dec;48(12):1594-604. doi: 10.1177/1060028014548310. Epub 2014 Aug 27.

PMID:
25163809
5.

Ceftriaxone induced hemolysis complicated by acute renal failure.

Kapur G, Valentini RP, Mattoo TK, Warrier I, Imam AA.

Pediatr Blood Cancer. 2008 Jan;50(1):139-42.

PMID:
16602117
6.

Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.

Dinesh D, Dugan N, Carter J.

Intern Med J. 2008 Jun;38(6):438-41. doi: 10.1111/j.1445-5994.2008.01656.x.

PMID:
18613898
7.

Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.

Arndt PA, Leger RM, Garratty G.

Transfusion. 2012 Mar;52(3):602-12. doi: 10.1111/j.1537-2995.2011.03321.x. Epub 2011 Aug 31.

PMID:
21880048
8.

Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.

Grossjohann B, Eichler P, Greinacher A, Santoso S, Kroll H.

Transfusion. 2004 Jul;44(7):1033-40.

PMID:
15225244
9.

Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature.

Seltsam A, Salama A.

Intensive Care Med. 2000 Sep;26(9):1390-4. Review.

PMID:
11089773
10.

Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.

Boggs SR, Cunnion KM, Raafat RH.

Pediatrics. 2011 Nov;128(5):e1289-92. doi: 10.1542/peds.2010-1570. Epub 2011 Oct 3. Review.

11.

Ceftriaxone-induced hemolysis.

Guleria VS, Sharma N, Amitabh S, Nair V.

Indian J Pharmacol. 2013 Sep-Oct;45(5):530-1. doi: 10.4103/0253-7613.117758.

12.

Ceftriaxone-related hemolysis and acute renal failure.

Demirkaya E, Atay AA, Musabak U, Sengul A, Gok F.

Pediatr Nephrol. 2006 May;21(5):733-6. Epub 2006 Feb 21.

PMID:
16491410
13.
14.

A severe case of cefoxitin-induced immune hemolytic anemia.

Leaf DE, Langer NB, Markowski M, Garratty G, Diuguid DL.

Acta Haematol. 2010;124(4):197-9. doi: 10.1159/000320169. Epub 2010 Nov 2.

PMID:
21042010
15.

Hemolytic anemia from ceftriaxone in an elderly patient: a case report.

Imam SN, Wright K, Bhoopalam N, Choudhury A.

J Am Med Dir Assoc. 2008 Oct;9(8):610-1. doi: 10.1016/j.jamda.2008.05.001.

PMID:
19083297
16.

Ceftriaxone-induced toxic hepatitis.

Peker E, Cagan E, Dogan M.

World J Gastroenterol. 2009 Jun 7;15(21):2669-71.

17.

Fatal immune haemolysis due to a degradation product of ceftriaxone.

Meyer O, Hackstein H, Hoppe B, Göbel FJ, Bein G, Salama A.

Br J Haematol. 1999 Jun;105(4):1084-5.

PMID:
10554824
18.

Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.

Kunzmann S, Thomas W, Mayer B, Kuhn S, Hebestreit H.

Infection. 2010 Apr;38(2):131-4. doi: 10.1007/s15010-009-9227-8. Epub 2010 Mar 5.

PMID:
20213286
19.

Acute hepatitis, autoimmune hemolytic anemia, and erythroblastocytopenia induced by ceftriaxone.

Longo F, Hastier P, Buckley MJ, Chichmanian RM, Delmont JP.

Am J Gastroenterol. 1998 May;93(5):836-7.

PMID:
9625142
20.

Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.

Moallem HJ, Garratty G, Wakeham M, Dial S, Oligario A, Gondi A, Rao SP, Fikrig S.

J Pediatr. 1998 Aug;133(2):279-81.

PMID:
9709722
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk